SUBSCRIBE
SUBSCRIBE

Roche

NEWS
Medicine’s Two-Headed Watchdog
October 19, 2005
 · 
1 min read
Policy
U.S. FDA Looks At Anemia Drugs, Cancer Risks
October 19, 2005
 · 
1 min read
Orlistat Inhibits Cancer Growth
October 19, 2005
 · 
2 min read
New Pill Helps Breast Cancer Care
October 19, 2005
 · 
1 min read
Deals
Paper: Novartis Eyes Big U.S. Acquisition
October 19, 2005
 · 
1 min read
Deals
Bayer AG, Others Eyeing Roche OTC Business; 2-3 Billion Swiss Francs (US $1.6-$2.4 Billion)
October 19, 2005
 · 
1 min read
Deals
Top 2003 Stories From The BioSpace NewsBeat
October 19, 2005
 · 
1 min read
Business
Novartis Enters “Good Cholesterol” Battle
October 19, 2005
 · 
1 min read
14th Annual Report: Top 100 Biotechnology Companies
October 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
 · 
16 min read
Press Releases
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
December 22, 2025
 · 
8 min read
Press Releases
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
December 17, 2025
 · 
3 min read
Press Releases
Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU
December 16, 2025
 · 
7 min read
Press Releases
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu
December 11, 2025
 · 
5 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
 · 
13 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
 · 
19 min read
Press Releases
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
December 9, 2025
 · 
11 min read
Press Releases
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
December 9, 2025
 · 
4 min read
Press Releases
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study
December 8, 2025
 · 
12 min read
Load More